Despite recent technological advances in radiotherapy, challenges relating to tumor targeting, dose limitations, and tumor relapse and escape remain. Multiple strategies for targeting cancer cells, cancer stem cells (CSCs), tumor stroma, and tumor endothelial cells (ECs), as well as improving anti-tumor immune responses to increase tumor radiosensitivity, are being developed
All news from Radiology/ Radiotherapy
Cryoablation, the destruction of cancer cells through freezing shows early indications of effectiveness in treating women with low-risk breast cancers, according to research being presented today at the annual meeting of the Radiological Society of North America (RSNA).
A new, large-scale study of more than 5 million mammograms found that annual mammography screening beginning at age 30 may benefit women with at least one of three specific risk factors: dense breasts, a personal history of breast cancer or a family history of breast cancer.
Two new studies being presented this week at the annual meeting of the Radiological Society of North America (RSNA) address the potential risk of cyber attacks in medical imaging. Researchers and cybersecurity experts have begun to examine ways to mitigate the risk of cyber attacks in medical imaging before they become a real danger.
The Ohio State University Wexner Medical Center and the Arthur G. James Cancer Hospital and Richard J. Solove Research Institute are collaborating with Nationwide Children’s Hospital to bring the first proton therapy treatment facility to central Ohio.
Interstitial brachytherapy uses slightly radioactive particles implanted into the prostate to deliver radiation directly to the tumor (low-dose-rate, LDR). Due to a lack of conclusive data, it still remains an unresolved issue as to whether this procedure has advantages compared with other treatments in men with localized prostate cancer.
It is possible to prevent certain injuries that can occur in radiation therapy against cancer. By blocking the activity of a plasma protein during and immediately after radiation, the patient can be protected against injury. This is shown in a new doctoral thesis at Umeå University, Sweden.
A drug increasingly used in combination with radiotherapy to treat a type of cancer that forms in the tonsils or the base of the tongue is inferior to a previously favored option, according to a large, clinical trial led by School of Medicine researchers that tracked patient survival and disease progression.
A new clinical study led by the University of Leicester and conducted in the HOPE clinical trials facility at Leicester's Hospitals has revealed the pivotal role that changing the time of day that a patient receives radiotherapy could play in altering radiotherapy toxicity.
Husband-and-wife doctors at the University of Virginia Cancer Center have been awarded more than $1.8 million from the National Institutes of Health for their effort to improve radiation therapy and breast surgery for patients with early-stage breast cancer.